1st Quarter - Termination — FAEGRE BAKER DANIELS CONSULTING for PARENT PROJECT MUSCULAR DYSTROPHY (2020)

Firm

FAEGRE BAKER DANIELS CONSULTING

Client

PARENT PROJECT MUSCULAR DYSTROPHY

Income

$10,000

Expenses

—

Terminated

Jan 31, 2020

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

NIH, CDC, and FDA issues relating to muscular dystrophy

Lobbyist	Covered position, as disclosed
MEGAN SUSSMAN HERBER New	Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA)
NICK MANETTO	Legislative Assistant, Rep. Christopher H. Smith (R-NJ)
DAVID RUSGAN ZOOK	—

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Defense, Dept of (DOD)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.